| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/11/1995 | US5432173 Psychological disorders |
| 07/11/1995 | US5432172 Biological applications of alkaloids derived from the tunicate Eudistoma sp. |
| 07/11/1995 | US5432171 Water soluble texaphyrin metal complexes for viral deactivation |
| 07/11/1995 | US5432169 Cyclopentanperhydrophenanthren-17β-(3-furyl)-3-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders |
| 07/11/1995 | US5432168 Method of treatment of hormone-unresponsive metastatic prostate cancer |
| 07/11/1995 | US5432167 Hyaluronic acid |
| 07/11/1995 | US5432166 Use of 1-(β-D-arabinofuranosyl) -5-propynyluracil for lowering serum cholesterol |
| 07/11/1995 | US5432165 Methods for the treatment of infection caused by Hepatitis B virus (HBV) |
| 07/11/1995 | US5432164 C2,N6 -disubstituted adenosine derivatives |
| 07/11/1995 | US5432163 Treating inflammatory, autoimmune disorders |
| 07/11/1995 | US5432161 Replacement for ascorbic acid |
| 07/11/1995 | US5432160 Contains beta-alanyl-L-glutamine |
| 07/11/1995 | US5432156 Therapeutic agent for digestive tract diseases |
| 07/11/1995 | US5431925 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression |
| 07/11/1995 | US5431922 Method for administration of buspirone |
| 07/11/1995 | US5431920 Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents |
| 07/11/1995 | US5431914 Topical administration |
| 07/11/1995 | US5431912 Cosmetic or dermopharmaceutical composition containing, in combination, a lauroylmethionate of a basic amino acid and at least one polyphenol |
| 07/11/1995 | US5431907 Treatment of vascular disorders of the posterior segment of the eye by topical administration of calcium channel blocking agents |
| 07/11/1995 | US5431896 Microbial immunoregulant |
| 07/11/1995 | US5431881 Treatment of hair loss and dermatological problems |
| 07/11/1995 | CA2139018A1 Cosmetic and/or dermatologic composition for the treatment of aging comprising ceramids, and its use |
| 07/11/1995 | CA1336287C Selective serotonin uptake inhibitors |
| 07/11/1995 | CA1336269C Expression of mammalian genes at high levels in host cells |
| 07/11/1995 | CA1336266C Medicaments |
| 07/11/1995 | CA1336265C Use of protriptyline for the treatment of mental health problems in children |
| 07/11/1995 | CA1336264C Pharmaceutical compositions containing deoxyribonucleosides for wound healing |
| 07/11/1995 | CA1336263C 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases |
| 07/10/1995 | EP0669918A4 Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them. |
| 07/07/1995 | CA2137998A1 Antimigraine derivatives of indolylcycloalkanylamines |
| 07/06/1995 | WO1995018226A1 Tuberous sclerosis 2 gene and uses thereof |
| 07/06/1995 | WO1995018225A1 Polycystic kidney disease 1 gene and uses thereof |
| 07/06/1995 | WO1995018223A1 Gene expression control |
| 07/06/1995 | WO1995018221A1 Gene coding for adseverins |
| 07/06/1995 | WO1995018144A1 Steroidal glycosides |
| 07/06/1995 | WO1995018143A1 Hypocholesterolemic agents |
| 07/06/1995 | WO1995018142A1 Wf15604 substances |
| 07/06/1995 | WO1995018141A1 Medicinal composition for bone resorption inhibition and osteogenesis acceleration |
| 07/06/1995 | WO1995018138A1 2'-deoxy-5-fluorouridine derivative, pharmaceutically acceptable salt thereof, process for producing the same, and antitumor drug |
| 07/06/1995 | WO1995018133A1 Amino alkanoic esters of rapamycin |
| 07/06/1995 | WO1995018132A1 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists |
| 07/06/1995 | WO1995018131A1 New ginkgolide derivatives and a process for preparing them |
| 07/06/1995 | WO1995018129A1 Diazabicyclic neurokinin antagonists |
| 07/06/1995 | WO1995018128A1 Pyrazolopyridine adenosine antagonists |
| 07/06/1995 | WO1995018126A1 Furylthiazole and their use as h2-receptor antagonism and antimicrobial |
| 07/06/1995 | WO1995018125A1 Isoxazolidinedione derivative and use thereof |
| 07/06/1995 | WO1995018124A1 Substituted morpholine derivatives and their use as therapeutic agents |
| 07/06/1995 | WO1995018120A1 [4-(1,2-epoxycyclohexanyl) but-3-en-1-ynyl] aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity |
| 07/06/1995 | WO1995018118A1 Heterocyclic compounds for the treatment of cns and cardiovascular disorders |
| 07/06/1995 | WO1995018114A1 Benzoxazine derivatives, methods for obtaining same and their use as drugs |
| 07/06/1995 | WO1995018109A1 Novel antiviral 2,4-pyrimidinedione derivatives and processes for the preparation thereof |
| 07/06/1995 | WO1995018107A1 Process for the preparation of leukotriene antagonists |
| 07/06/1995 | WO1995018105A1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists |
| 07/06/1995 | WO1995018103A1 7-[carboxyalkyl or alkenyl]-6-[alkyl or alkenyl] 3-oxo-2,4-dioxobicyclo-[3.2.1] octane and derivatives thereof |
| 07/06/1995 | WO1995018102A1 Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
| 07/06/1995 | WO1995018101A1 Prostaglandin derivative, salt thereof, and use thereof |
| 07/06/1995 | WO1995018099A1 Aminocarboxylic acid amides, process for preparing the same and their use as anti-arrhythmic agents |
| 07/06/1995 | WO1995018097A1 Anthranilic acid derivative |
| 07/06/1995 | WO1995018091A1 Unsaturate amino compounds for use as anticancer and antiprotozoic agent |
| 07/06/1995 | WO1995018084A1 Process for isomerizing linear olefins to isoolefins |
| 07/06/1995 | WO1995017906A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 07/06/1995 | WO1995017903A1 Modular design and synthesis of oxazolone-derived molecules |
| 07/06/1995 | WO1995017901A1 Methods and compositions for the treatment of a host with a cellular proliferative disease |
| 07/06/1995 | WO1995017900A1 Methods for the treatment of the central nervous system or eye involving pathogenic oxidation pathways |
| 07/06/1995 | WO1995017898A1 A method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans |
| 07/06/1995 | WO1995017897A1 Non-methylene interrupted fatty acids as immunomodulators |
| 07/06/1995 | WO1995017896A1 Percutaneously absorbable preparation |
| 07/06/1995 | WO1995017895A1 Means and method for hormonal contraception and/or the treatment of acne |
| 07/06/1995 | WO1995017894A1 Use of pyridone derivatives as anesthetic drugs |
| 07/06/1995 | WO1995017893A1 Methods for preventing or treating hiv-1 or hiv-2 infection |
| 07/06/1995 | WO1995017892A1 Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis |
| 07/06/1995 | WO1995017891A1 2,3-diaryl-1-benzopyrans for treating dermatitis |
| 07/06/1995 | WO1995017890A1 Method of treatment of traumatic brain injury |
| 07/06/1995 | WO1995017889A1 Therapeutic composition for hyperparathyroidism of patient subjected to artificial dialysis |
| 07/06/1995 | WO1995017888A1 Phenylmethyl hexanamides, and the use thereof |
| 07/06/1995 | WO1995017887A1 Method of treatment of hormone-unresponsive metastatic prostate cancer |
| 07/06/1995 | WO1995017886A1 Water soluble non-immunogenic polyamide cross-linking agents |
| 07/06/1995 | WO1995017883A1 Water-in-oil lotion containing a corticosteroid |
| 07/06/1995 | WO1995017882A1 Corticosteroid-containing w/o emulsion lotion |
| 07/06/1995 | WO1995017876A2 2,4-disulphophenyl butylnitrone, its salts, and their use as pharmaceutical spintraps |
| 07/06/1995 | WO1995017875A2 MIXTURES OF DIDEOXYNUCLEOSIDES AND D-ASPARTIC ACID β-HYDROXAMATE FOR INHIBITING RETROVIRAL SPREAD |
| 07/06/1995 | WO1995016435A3 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent |
| 07/06/1995 | WO1995011984A3 Recombinant adenoviral vector and methods of use |
| 07/06/1995 | CA2180260A1 Methods and compositions for the treatment of a host with a cellular proliferative disease |
| 07/06/1995 | CA2180253A1 Pyrazolopyridine adenosine antagonists |
| 07/06/1995 | CA2180177A1 2,3-diaryl-1-benzopyrans for treating dermatitis |
| 07/06/1995 | CA2180149A1 Steroidal glycosides |
| 07/06/1995 | CA2180148A1 Hypocholesterolemic agents |
| 07/06/1995 | CA2180014A1 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists |
| 07/06/1995 | CA2180009A1 ¬4-(1,2-epoxycyclohexanyl) but-3-en-1-ynyl| aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity |
| 07/06/1995 | CA2179981A1 Prostaglandin derivative, salt thereof, and use thereof |
| 07/06/1995 | CA2179824A1 Method of treatment of traumatic brain injury |
| 07/06/1995 | CA2179810A1 Aminocarboxylic acid amides, process for preparing the same and their use as anti-arrhythmic agents |
| 07/06/1995 | CA2179422A1 Means and method for hormonal contraception and/or the treatment of acne |
| 07/06/1995 | CA2179307A1 Amino alkanoic esters of rapamycin |
| 07/06/1995 | CA2177736A1 New ginkgolide derivatives and a process for preparing them |
| 07/06/1995 | CA2176824A1 Percutaneously absorbable preparation |
| 07/06/1995 | CA2176722A1 Heterocyclic compounds for the treatment of cns and cardiovascular disorders |
| 07/06/1995 | CA2156924A1 Water soluble non-immunogenic polyamide cross-linking agents |
| 07/06/1995 | CA2155662A1 Anthranilic acid derivative |